Browse

RETROAURICULAR THYROIDECTOMY WITH A NEXT-GENERATION SINGLE-PORT ROBOTIC SURGERY SYSTEM: PRECLINICAL STUDIES AND FIRST IN HUMAN CASE

Endocrine

Tyler Okland, MD¹, Myung-Chul Lee, MD², Kenric Tam, MD³, Estelle Chang, MD⁴, Eun Chang Choi, MD⁵, Floyd Christopher Holsinger, MD¹, Yoon Woo Koh, MD⁵

¹Stanford University, ²Korea Cancer Center Hospital, ³University of California -- Los Angeles School of Medicine, ⁴University of Nebraska, ⁵Yonsei University

THYROID LOBECTOMY PROVIDES IMPROVED VALUE OVER TOTAL THYROIDECTOMY IN WELL-SELECTED PATIENTS WITH INTERMEDIATE RISK DIFFERENTIATED THYROID CARCINOMA

Endocrine

Olivia Do, MS1, Andrew J Thomas, MD, Richard Cannon, MD, Jason Hunt, MD, Luke Buchmann, MD, Dev Abraham, MD, Marcus M Monroe, MD, FACS, Mia Hashibe, PhD

University of Utah School of Medicine

UTILITY OF PRE-OPERATIVE LOCALIZATION STUDIES IN DIAGNOSING THE INTRA-THYROIDAL PARATHYROID ADENOMA

Endocrine

Julia Noel, MD¹, Ida Solis, MD², Ramin Saket, MD³, Peter Shen, MD³, Mark Mamlouk, MD³, Ryan Niederkohr, MD³, Sumeer Gupta², Lisa Orloff, MD¹, Michael Friduss, MD³

¹Stanford University, ²Kaiser Permanente San Francisco, ³Kaiser Permanente Santa Clara

THE SURGICAL MANAGEMENT OF RETROPHARYNGEAL LYMPH NODE METASTASIS IN DIFFERENTIATED THYROID CARCINOMA

Endocrine

Victoria Harries, MBBS, Marlena McGill, BS, Laura Y Wang, MBBS, MS, Ashok R Shaha, MD, Jatin P Shah, MD, Richard J Wong, MD, R M Tuttle, MD, Snehal Patel, MD, Ian Ganly, MD, PhD

Memorial Sloan Kettering Cancer Center

PREDICTIVE MODELING OF OPERATIVE TIME WITH TRANSORAL ENDOSCOPIC THYROIDECTOMY VESTIBULAR APPROACH (TOETVA)

Endocrine

Christopher R Razavi, MD, Lena W Chen, BA, Rohit Ranganath, MD, Ralph P Tufano, MD, MBA, Jonathon O Russell, MD

Johns Hopkins Department of OHNS

LYMPH NODE RATIO AND OVERALL SURVIVAL IN PAPILLARY THYROID CANCER

Endocrine

Blaine D Smith, MD, Samantha M Thomas, MS, Taofik Oyekunle, MS, Daniel J Rocke, MD, JD

Duke University Medical Center

INVESTIGATING THE POTENTIAL ROLE OF ANTI-PD-L1 IMMUNOTHERAPY IN AGGRESSIVE PAPILLARY THYROID CARCINOMA

Endocrine

L Boven¹, S Terhoeve¹, A Gundale¹, B Beatrous¹, T Moore-Medlin¹, J McLarty¹, X Ma¹, H Savage¹, X Gu¹, R Ranganath², C Nathan¹

¹LSU Health, ²Johns Hopkins

KI-67 AND CK-19 ARE INDEPENDENT PREDICTORS OF LOCOREGIONAL RECURRENCE IN PAPILLARY THYROID CARCINOMA

Endocrine

Luiz Paulo Kowalski, PhD, MD

A C Camargo Cancer Center, Sao Paulo, Brazil

THE EVOLUTION OF PAPILLARY THYROID CANCER DURING PREGNANCY.

Endocrine

Sriram Navuluri, Christopher M Yao, MD, Justin Tran, Mark Zafereo, MD, FACS

University of Texas MD Anderson Cancer Center

USE OF OUTCOMES DATA TO STANDARDIZE MANAGEMENT OF POSTOPERATIVE HYPOCALCEMIA AFTER HEAD AND NECK ENDOCRINE SURGERY

Endocrine

Marcus J Magister, MD, Thomas Fitzpatrick, BS, Joshua Waltonen, MD, Brittany Henderson, MD, Christopher A Sullivan, MD

Wake Forest Baptist Medical Center